SCHEMBL9957935

SCHEMBL9957935

O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(OCc3ccccc3)cc(O)c12

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.68
KMT2A Q03164 5/20 0.68
CYP3A4 P08684 4/20 0.68
MAPT P10636 4/20 0.68
KDM4E B2RXH2 3/20 0.68
RECQL P46063 3/20 0.68
HSD17B10 Q99714 3/20 0.68
LMNA P02545 2/20 0.68
APP P05067 2/20 0.68
THRB P10828 2/20 0.68
AKR1B1 P15121 2/20 0.68
ELAVL3 Q14576 2/20 0.68
IPMK Q8NFU5 2/20 0.68
TDP1 Q9NUW8 2/20 0.68
IP6K2 Q9UHH9 2/20 0.68
BCL9 O00512 3/20 0.65
CTNNB1 P35222 3/20 0.65
CYP1A2 P05177 3/20 0.65
CYP2C9 P11712 3/20 0.65
ABCB1 P08183 3/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27919434 0.91 XDH (0.63) MEN1KMT2ACYP3A4MAPTKDM4E
SCHEMBL12621081 0.91 ABCB1 (0.62) MEN1KMT2ACYP3A4MAPTKDM4E
SCHEMBL14254531 0.89 ACE2 (0.59) MEN1KMT2ACYP3A4MAPTKDM4E
SCHEMBL27897199 0.88 MEN1 (0.78) MEN1KMT2ACYP3A4MAPTKDM4E
SCHEMBL28415079 0.86 MEN1 (0.74) MEN1KMT2ACYP3A4MAPTKDM4E
SCHEMBL15228351 0.86 NOX4 (0.69) MEN1KMT2ACYP3A4MAPTKDM4E
SCHEMBL5126336 0.85 MEN1 (0.69) MEN1KMT2ACYP3A4MAPTKDM4E
SCHEMBL13056280 0.85 MEN1 (0.52) MEN1KMT2ACYP3A4MAPTKDM4E
SCHEMBL21823965 0.85 MEN1 (0.72) MEN1KMT2ACYP3A4MAPTKDM4E
SCHEMBL29369747 0.85 MEN1 (0.72) MEN1KMT2ACYP3A4MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013130020-A1 QUERCETIN DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE ÚSTAV EXPERIMENTÁLNEJ FARMAKOLÓGIE A TOXIKOLÓGIE SAV (SK) 2013-09-06 WO disclosed
EP-2468741-A1 Novel quercetin derivatives, their preparation, pharmaceutical compositions containing them and their use Bel/Novamann International s.r.o. (SK) 2012-06-27 EP disclosed